Locksley Resources (ASX: LKY) hits 99.5% purity antimony trioxide milestone, opening U.S. defense supply chain pathway
How Accenture is using Google Cloud and Wiz to close security blind spots in modern multi-cloud infrastructure
Read More 4 minute read Pharma Industry News Merck KGaA to acquire SpringWorks Therapeutics in $3.9bn rare tumor expansion Find out how Merck KGaA, Darmstadt, Germany’s $3.9 billion SpringWorks acquisition is reshaping rare tumor treatment and global healthcare leadership. byPallavi MadhirajuApril 28, 2025